Nipah virus (NiV) infection is a zoonotic disease caused by the Nipah virus, primarily found in bats of the Pteropus genus. Since its identification in 1999 during an outbreak in Malaysia, NiV has emerged as a significant public health concern, particularly in Southeast Asia. This abstract provides a comprehensive overview of Nipah virus infection, covering its epidemiology, transmission, clinical manifestations, diagnosis, treatment, prevention, and global health implications. Epidemiology: Nipah virus outbreaks have been reported in various countries, including Singapore, India, Malaysia, and Bangladesh. Fruit bats serve as the natural reservoir of NiV, with transmission to humans typically occurring through the consumption of contaminated fruits or direct exposure to bat excreta. Transmission: Human-to-human transmission of the Nipah virus (NiV) primarily occurs through close contact with infected individuals or their bodily fluids. Nosocomial transmission has been documented during outbreaks, underscoring the critical need for infection control measures in healthcare settings. Clinical manifestations of NiV infection vary widely, ranging from mild febrile illness to severe respiratory and neurological complications, such as encephalitis. The case-fatality rates during outbreaks can vary widely, ranging from 40% to 100%. Diagnosis and Treatment: Diagnosing NiV infection can be difficult because its clinical symptoms are not specific. Laboratory testing, including molecular assays and serological methods, is essential for accurate
diagnosis. Currently, there are no specific antiviral treatments for NiV infection, and management mainly involves providing supportive care to alleviate symptoms and complications. Prevention and Control: Preventing Nipah virus outbreaks requires a multifaceted approach, including surveillance of bat populations, early detection of cases, rapid response to outbreaks, and implementation of infection control measures in healthcare settings. Vaccines and antiviral drugs targeting NiV are under development, offering promising avenues for future prevention and treatment efforts. Global Health Implications: Nipah virus infection poses significant challenges to global health security due to its potential for international spread and high case-fatality rates. Cooperation between nations and international organizations is crucial for the effective prevention and management of NiV outbreaks.

Keywords: Nipah virus, Zoonotic disease, Epidemiology, Transmission, Public health.

🔒 This is a subscription article

Full text is available to subscribers and institutional members. Please choose an option below to access it.

Nipah virus (NiV) infection is a zoonotic disease caused by the Nipah virus, primarily found in bats of the Pteropus genus. Since its identification in 1999 during an outbreak in Malaysia, NiV has emerged as a significant public health concern, particularly in Southeast Asia. This abstract provides a comprehensive overview of Nipah virus infection, covering its epidemiology, transmission, clinical manifestations, diagnosis, treatment, prevention, and global health implications. Epidemiology: Nipah virus outbreaks have been reported in various countries, including Singapore, India, Malaysia, and Bangladesh. Fruit bats serve as the natural reservoir of NiV, with transmission to humans typically occurring through the consumption of contaminated fruits or direct exposure to bat excreta. Transmission: Human-to-human transmission of the Nipah virus (NiV) primarily occurs through close contact with infected individuals or their bodily fluids. Nosocomial transmission has been documented during outbreaks, underscoring the critical need for infection control measures in healthcare settings. Clinical manifestations of NiV infection vary widely, ranging from mild febrile illness to severe respiratory and neurological complications, such as encephalitis. The case-fatality rates during outbreaks can vary widely, ranging from 40% to 100%. Diagnosis and Treatment: Diagnosing NiV infection can be difficult because its clinical symptoms are not specific. Laboratory testing, including molecular assays and serological methods, is essential for accurate
diagnosis. Currently, there are no specific antiviral treatments for NiV infection, and management mainly involves providing supportive care to alleviate symptoms and complications. Prevention and Control: Preventing Nipah virus outbreaks requires a multifaceted approach, including surveillance of bat populations, early detection of cases, rapid response to outbreaks, and implementation of infection control measures in healthcare settings. Vaccines and antiviral drugs targeting NiV are under development, offering promising avenues for future prevention and treatment efforts. Global Health Implications: Nipah virus infection poses significant challenges to global health security due to its potential for international spread and high case-fatality rates. Cooperation between nations and international organizations is crucial for the effective prevention and management of NiV outbreaks.

Keywords: Nipah virus, Zoonotic disease, Epidemiology, Transmission, Public health.

🔒 This is a subscription article

Full text is available to subscribers and institutional members. Please choose an option below to access it.